This post has been archived and contains information that may be out of date.
CHA DataSuite has issued a hospital-specific analysis of the federal fiscal year (FFY) 2024 Medicare inpatient hospital-acquired condition (HAC) reduction program.
The analysis, which was designed in the business intelligence platform, is intended to provide hospitals with a preview of the potential impact of the program based on publicly available data and program rules established by the Centers for Medicare & Medicaid Services (CMS).
In this analysis, hospital performance is evaluated under the FFY 2024 program. The analysis uses the fourth quarter 2022 update of Care Compare for healthcare-associated infection (HAI) measures and the second quarter 2021 update of Care Compare for patient safety indicator-90. It includes estimates and details on how HAC measures and domain scores are calculated as well as how payment penalties are determined and applied under the program.
For FFY 2023 HAC reduction program, CMS is not penalizing any hospitals due to the impact of the COVID-19 pandemic. CMS did provide a subset of data for individual measures but did not provide total HAC scores and therefore no impacts are calculated. For FFY 2024 HAC reduction program, the performance periods are impacted by the extraordinary circumstances exception granted by CMS in response to the public health emergency. As a result, no claims data for chart-abstracted data reflecting services provided in calendar years 2020 or 2021 for HAI measures will be used in calculations for the HAC reduction program.
